Position in WHWK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,924,196
+$4,754,181 QoQ
Shares Held
4,615,709
0.0% QoQ
Ownership
9.33%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WHWK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026QVT Financial LP holds $745,266,368 across 8 Biotechnology names. WHWK ranks #2 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
25,161,237 | $696,966,264 | |
| 2 | WHWK |
Whitehawk Therapeutics, Inc.
This page
|
4,615,709 | $15,924,196 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
699,301 | $10,111,892 | |
| 4 | ZURA |
Zura Bio Ltd
|
1,310,593 | $7,798,028 | |
| 5 | SMMT |
Summit Therapeutics Inc.
|
360,524 | $6,835,535 | |
| 6 | ARGX |
Argenx SE
|
5,218 | $3,810,444 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
678,564 | $2,381,759 | |
| 8 | BHVN |
Biohaven Ltd.
|
170,006 | $1,438,250 |
All Filings in WHWK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,924,196 | 4,615,709 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,170,015 | 4,615,709 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,769,847 | 4,615,709 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,631,375 | 4,615,709 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,037,962 | 4,515,709 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,299,729 | 2,313,702 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $7,299,729 | 2,313,702 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||